Assistant Director of Genomics Operation
Elmwood Park, NJ
This is an exciting time to join our dynamic organization. OPKO Health is a diversified healthcare company that seeks to establish industry-leading positions in large, rapidly growing markets, including pharmaceuticals, diagnostics, and biologics. OPKO's diagnostics business includes BioReference Laboratories, the nation's third-largest and fastest growing clinical laboratory over the last 35 years, which provides diagnostic testing to physician offices, hospitals, and clinics, among others, and GeneDx, a rapidly growing genetics and genomics laboratory that applies cutting edge technologies to make efficient clinical diagnostic testing and interpretation available for individuals with rare and common genetic conditions. Come join our team and become part of something big, by making our patients and customers the highest priority.
A full-time position is available for an Assistant Director of Genomics Operations with a background in genomics and molecular oncology and in the growing Genomics Program at Bio-Reference Laboratories. The Assistant Director of Genomic Operations is responsible for overseeing the day-to-day operations of the Genomic testing programs. Under the direction of the Director of Genomics, Vice President of Genomics, or Laboratory Director, the Assistant Director is responsible for day-to-day management of laboratory technicians and technologists, various NGS and array based testing, maintaining department fiscal responsibility, working with Rand D to transfer and validate new assays, managing supervisors and helping them perform their duties related to ongoing quality monitoring and improvement. In addition, he/she participates in creating and maintaining all the documentation associated to regulatory agencies for his/her position, and monitoring employee performance.
In this role, you will lead a team of scientists, genetic counselors and board certified directors to support our genomic testing program. This program has experienced tremendous growth in the analysis of both solid and liquid tumors, with the continual launch of novel tests.